Global expansion B-Temia has a track record of international activity, including Asia market launches and partnerships with Wistron, suggesting strong growth potential in global mobility assistance markets and opportunities to cross-sell to regional distributors.

Strategic partnerships Past collaborations with Lockheed Martin Ventures, NSRDEC, and Wistron indicate receptiveness to enterprise and government/defense or large-scale deployment channels, signaling a path for enterprise-grade solutions and integration opportunities.

Dermoskeleton value Keeogo Dermoskeleton technology positions B-Temia in the human mobility augmentation space, presenting a compelling use case for hospitals, rehab centers, elder care facilities, and insurance-led mobility programs seeking advanced assistive devices.

Public focus Recognition as a high-technology finalist and ongoing media coverage imply credibility and visibility that can be leveraged when approaching potential customers and partners in healthcare, defense-adjacent sectors, and research institutions.

Financial runway With revenue in the low-to-mid seven figures and funding secured, there is room to scale field deployments, support services, and after-sales CE/regulatory activities while targeting larger procurement opportunities.